Advisory Committee to the Director, Centers for Disease Control and Prevention (ACD, CDC), 20325 [E9-10051]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 83 / Friday, May 1, 2009 / Notices
standard for use in ruminant feed, and
if so whether this requirement is
consistent with FDA’s requirement that
tallow for human food and cosmetics be
free of prohibited material or contain
less than 0.15 percent insoluble
impurities;
• Whether the impurity standard
applies to blended fats and oils;
• Whether a renderer can be held
responsible for the impurity level in
tallow after it is delivered to a
customer’s storage tanks;
• Whether the new regulation applies
to cattle material fed to mink; and
finally,
• A request to use the word
‘‘effective’’ in the guidance when
referring to the removal of brains and
spinal cords of cattle.
FDA has responded to these comments
and concerns in the question and
answer portion of the final guidance.
The guidance announced in this notice
finalizes the draft guidance dated
November 25, 2008.
II. Significance of Guidance
This level 1 guidance is being issued
consistent with FDA’s good guidance
practices regulation (21 CFR 10.115).
The guidance represents the agency’s
current thinking on the topic. It does not
create or confer any rights for or on any
person and does not operate to bind
FDA or the public. An alternative
approach may be used if such approach
satisfies the requirements of the
applicable statutes and regulations.
III. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
21 CFR 589.2001 have been approved
under OMB control number 0910–0627.
IV. Comments
Submit written requests for single
copies of the guidance to the
Communications Staff (HFV–12), Center
for Veterinary Medicine, Food and Drug
Administration, 7519 Standish Pl.,
Rockville, MD 20855. Send one selfaddressed adhesive label to assist that
office in processing your requests.
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
VerDate Nov<24>2008
15:15 Apr 30, 2009
Jkt 217001
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
V. Electronic Access
Persons with access to the Internet
may obtain the guidance at either https://
www.fda.gov/cvm or https://
www.regulations.gov.
Dated: April 27, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–10034 Filed 4–30–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director,
Centers for Disease Control and
Prevention (ACD, CDC)
Notice of Cancellation: This notice
was published in the Federal Register
on April 13, 2009, Volume 74, Number
69, page 16877. The meeting previously
scheduled to convene on April 30, 2009
has been cancelled.
Contact Person for More Information:
Brad Perkins, M.D., M.B.A., ACD, CDC,
1600 Clifton Road, NE., Mail Stop D–14,
Atlanta, GA 30303; Telephone: (404)
639–7000.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: April 27, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–10051 Filed 4–30–09; 8:45 am]
20325
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned review group:
Times and Date:
12:30 p.m.–1 p.m., May 20, 2009 (Open).
1 p.m.–3 p.m., May 20, 2009 (Closed).
Place: Teleconference, Toll Free: 888–793–
2154, Participant Passcode: 4424802.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of individual research cooperative
agreement applications submitted in
response to Fiscal Year 2009 Requests for
Applications related to the following
individual research announcement: RFA–
EH–09–002 ‘‘Program to Expand State Public
Health Laboratory Capacity for Newborn
Bloodspot Screening (U01)’’.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information: Jane
Suen, Dr.P.H., M.S., NCIPC, CDC, 4770
Buford Highway, NE., Mailstop F–62,
Atlanta, Georgia 30341, Telephone: (770)
488–4281.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–10031 Filed 4–30–09; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Injury Prevention
and Control, Initial Review Group
(NCIPC, IRG)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel, May
18, 2009, 8 a.m. to May 18, 2009, 5 p.m.,
St. Gregory Hotel, 2033 M Street, NW.,
E:\FR\FM\01MYN1.SGM
01MYN1
]]>Agencies
[Federal Register Volume 74, Number 83 (Friday, May 1, 2009)]
[Notices]
[Page 20325]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-10051]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director, Centers for Disease Control
and Prevention (ACD, CDC)
Notice of Cancellation: This notice was published in the Federal
Register on April 13, 2009, Volume 74, Number 69, page 16877. The
meeting previously scheduled to convene on April 30, 2009 has been
cancelled.
Contact Person for More Information: Brad Perkins, M.D., M.B.A.,
ACD, CDC, 1600 Clifton Road, NE., Mail Stop D-14, Atlanta, GA 30303;
Telephone: (404) 639-7000.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: April 27, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-10051 Filed 4-30-09; 8:45 am]
BILLING CODE 4163-18-P
